Related Experiment Video
Updated: Aug 12, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
A vaccine against coccidioidomycosis is justified and attainable
1Department of Microbiology and Immunology, Medical College of Ohio, Toledo, Ohio 43614, USA.
Abstract:
Coccidioides is a fungal pathogen of humans which can cause a life-threatening respiratory disease in immunocompetent individuals. Recurrent epidemics of coccidioidal infections in Southwestern United States has raised the specter of awareness of this soil-borne microbe, particularly among residents of Arizona and Southern California, and has galvanized research efforts to develop a human vaccine against coccidioidomycosis. In this review, we discuss the rationale for such a vaccine, examine the features of host innate and acquired immune response to Coccidioides infection, describe strategies used to identify and evaluate vaccine candidates, and provide an update on progress toward development of a vaccine against this endemic pathogen.
Related Concept Videos
Vaccinations
Infectious Diseases and Their Occurrence
Vaccines
Smallpox
Cryptococcal Meningitis
Candidiasis

